| Molecular formula | C33H57N11O9 |
|---|
| Molecular weight | 751.9 g/mol |
|---|
| Registered trials | 10 |
|---|
| PubChem CID | 11765600 |
|---|
Regulatory status
Selank is not approved by the FDA for any use. No FDA label, indication, or verified mechanism of action exists for this compound in the data reviewed. It is classified here as an unapproved research compound.
What selank is
Selank is a synthetic peptide with the molecular formula C33H57N11O9 and a molecular weight of about 751.9 g/mol (PubChem CID 11765600). Because no approved drug label exists, there is no FDA-recognized drug class, mechanism of action, or indication to report for it.
Trial footprint
Ten trials referencing selank are registered. Trials identified in the sample include a completed study on balance exercises and cognitive function, a neurofeedback training study for dyslexia with unknown status, and a completed trial of telephone-based psychotherapy for depression with and without adjunctive supportive mail. Listing in a trial registry does not indicate that selank was shown to be safe or effective for any purpose, and these registry entries do not establish a development phase for the compound.
FAQ
No. Selank has no FDA-approved label, and it is classified as an unapproved research compound. There is no verified indication or mechanism of action on file for it.
Selank is a synthetic peptide with the molecular formula C33H57N11O9 and a molecular weight of approximately 751.9 g/mol. Its chemical identity is catalogued under PubChem CID 11765600.
Ten trials in the registry reference selank. These include studies on topics such as balance exercises and cognitive function, neurofeedback training for dyslexia, and telephone-based psychotherapy for depression.
No. Being listed in a clinical trial registry does not mean a compound has been proven safe or effective. The trials identified vary in status, including completed and unknown, and do not establish efficacy for selank.
No adverse event report data was available for selank in the reviewed sources. Because no approved label exists, there is also no FDA-reviewed safety profile to summarize.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-11-07